186 related articles for article (PubMed ID: 30476254)
1. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
3. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
Pape L; Tönshoff B; Hirsch HH;
Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
[TBL] [Abstract][Full Text] [Related]
4. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
[TBL] [Abstract][Full Text] [Related]
5. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
7. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
8. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.
Hirsch HH; Yakhontova K; Lu M; Manzetti J
Am J Transplant; 2016 Mar; 16(3):821-32. PubMed ID: 26639422
[TBL] [Abstract][Full Text] [Related]
9. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
10. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
11. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.
Steubl D; Baumann M; Schuster T; Fischereder M; Krämer BK; Heemann U; Lutz J
Scand J Urol Nephrol; 2012 Dec; 46(6):466-74. PubMed ID: 23016678
[TBL] [Abstract][Full Text] [Related]
13. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
[TBL] [Abstract][Full Text] [Related]
14. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
15. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation.
Krejčí K; Tichý T; Bednaříková J; Bartková M; Žamboch K; Orság J; Zadražil J
J Med Virol; 2021 Jun; 93(6):3871-3879. PubMed ID: 32940913
[TBL] [Abstract][Full Text] [Related]
17. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
[TBL] [Abstract][Full Text] [Related]
18. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
[TBL] [Abstract][Full Text] [Related]
19. BK virus nephropathy after simultaneous pancreas-kidney transplantation.
Akpinar E; Ciancio G; Sageshima J; Chen L; Guerra G; Kupin W; Roth D; Ruiz P; Burke G
Clin Transplant; 2010; 24(6):801-6. PubMed ID: 20088913
[TBL] [Abstract][Full Text] [Related]
20. Impact of pre-graft serology on risk of BKPyV infection post-renal transplantation.
François C; Tinez C; Brochot E; Duverlie G; Castelain S; Helle F; Fiore T; Morel V; Touzé A; Sater FA; Dakroub F; Akl H; Presne C; Choukroun G; Guillaume N
Nephrol Dial Transplant; 2022 Mar; 37(4):781-788. PubMed ID: 34586413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
